Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030552 (
paresis
)
5,831
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In 40 patients with insulin-dependent diabetes mellitus, the number of
gastrin
cells in the mucous membrane of the antrum of the stomach was measured by immunohistochemistry according to the method of L. Sternberger. The number of the cells depended on the gravity of antral gastritis, namely their number decreased as the lesion was aggravated. The basal level of serum
gastrin
was determined by radioimmunoassay in 144 patients with insulin-dependent diabetes mellitus. The high basal level of
gastrin
was recorded in patients with achlorhydria. However, no correlation was established between the gravity of antral gastritis and the basal level of serum
gastrin
. If the basal
gastrin
level is too high, the possibility of asymptomatic
paresis
of the stomach should be taken into account together with the other factors.
...
PMID:[Gastrin cells and the basal level of serum gastrin in patients with insulin-dependent diabetes mellitus]. 351 19
We have developed and validated a double-antibody radioimmunoassay for quantifying bovine calcium-binding protein (CaBP). Cross-reactivity between the antiserum and microgram quantities of thyrocalcitonin, calmodulin,
gastrin
, cholecystokinin, vasoactive intestinal polypeptide, serum albumin and concentrated extract of bovine pituitary gland was insignificant. Slight cross-reactivity (6%) of the antiserum with parathyroid hormone was demonstrated. Assay sensitivity was .25 ng/ml and intraassay and interassay coefficients of variation ranged from 4 to 11% and 10 to 24%, respectively. The CaBP immunoreactivity was not affected by endogenous Ca concentrations. Plasma and serum concentrations of immunoreactive CaBP were similar. The CaBP concentrations were unaffected when coagulated and anticoagulated blood samples were stored at 4 or 22 C for up to 72 h and when serum was stored at -20, 4 or 22 C for 8 d. Serum CaBP concentrations in cattle were not affected by gonadal steroids, but may have been influenced by age. Treatment with 500 mg of vitamin D3, but not 50 mg of dihydrotachysterol, significantly increased serum Ca and CaBP concentrations in Holstein heifers after a lag period of 7 to 10 d. Serum Ca and CaBP concentrations began to increase in serum at approximately the same time and both exhibited parallel responses to treatment with vitamin D3. Serum Ca concentrations were positively correlated (r = .81) with CaBP concentrations and this relationship was described by the equation, Y = 6.85 + 1.01X - .03X2. Serum Ca and CaBP concentrations were still elevated in heifers 75 d after initial treatment with vitamin D3. The radioimmunoassay we describe provides an opportunity to investigate the role of CaBP in Ca homeostasis during growth, pregnancy, lactation, parturient
paresis
and other physiological and pathological states in cattle.
...
PMID:Studies of calcium-binding protein in cattle. 631 69
There are (at least) two types of receptor for cholecystokinin (CCK)/
gastrin
peptides. Highly potent specific antagonists are available for both types. The CCKA-receptor mediates classical CCK-like effects on the gut. Antagonists given to man inhibit pancreatic enzyme secretion and generally shorten gastrointestinal transit times. Potential clinical indications include anorexia, gastro-
paresis
, pseudo-
paresis
, pseudo-obstruction, severe constipation and chronic pancreatitis. However gallbladder contraction is markedly inhibited and this led to gallstone formation in baboons. This will obviously have to be avoided if CCKA antagonists are to be used in man. CCKB-receptors mediate the effects of
gastrin
on the gut and the effects of CCK in the brain. They inhibit
gastrin
-stimulated acid secretion. If used in acid-peptic disease they might inhibit the trophic effects of
gastrin
on enterochromaffin cells. CCKB-antagonists can also inhibit the growth of some
gastrin
-dependent tumours, including certain human colonic cancer cell lines which produce
gastrin
. CCKB-antagonists have a potent anxiolytic-like effect in animals, and this effect might become their main clinical application.
...
PMID:CCK/gastrin antagonists--clinical perspectives. 826 65